Cassava Sciences Inc (SAVA):企業の財務・戦略的SWOT分析

◆英語タイトル:Cassava Sciences Inc (SAVA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH32079FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cassava Sciences Inc (SAVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cassava Sciences Inc (Cassava Sciences), formerly known as Pain Therapeutics Inc is a clinical-stage biopharmaceutical company that develops drugs for the treatment of severe pain and neurodegenerative diseases, with a special focus on Alzheimer’s disease. The company’s lead product candidate PTI-125 is a small molecule being developed for the treatment of Alzheimer’s disease. It is in Phase II clinical trial in patients with Alzheimer’s disease. The company is also developing PTI-125Dx, a blood-based biomarker/diagnostic for the detection of Alzheimer’s disease; Fenrock, a proprietary abuse-deterrent transdermal pain patch for treating severe pain. Cassava Sciences is headquartered in Austin, Texas, the US.

Cassava Sciences Inc Key Recent Developments

Nov 09,2020: Cassava Sciences reports third quarter 2020 financial results
Aug 12,2020: Cassava Sciences announces second quarter 2020 financial results and mid-year business review
Jun 18,2020: Cassava Sciences: Departure of board of directors
May 06,2020: Cassava Sciences reports first quarter 2020 financial results and provides business update
Mar 26,2020: Cassava Sciences announces full-year 2019 financial results and anticipated key milestones for 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Cassava Sciences Inc – Key Facts
Cassava Sciences Inc – Key Employees
Cassava Sciences Inc – Key Employee Biographies
Cassava Sciences Inc – Major Products and Services
Cassava Sciences Inc – History
Cassava Sciences Inc – Company Statement
Cassava Sciences Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Cassava Sciences Inc – Business Description
Cassava Sciences Inc – SWOT Analysis
SWOT Analysis – Overview
Cassava Sciences Inc – Strengths
Cassava Sciences Inc – Weaknesses
Cassava Sciences Inc – Opportunities
Cassava Sciences Inc – Threats
Cassava Sciences Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Cassava Sciences Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 09, 2020: Cassava Sciences reports third quarter 2020 financial results
Aug 12, 2020: Cassava Sciences announces second quarter 2020 financial results and mid-year business review
Jun 18, 2020: Cassava Sciences: Departure of board of directors
May 06, 2020: Cassava Sciences reports first quarter 2020 financial results and provides business update
Mar 26, 2020: Cassava Sciences announces full-year 2019 financial results and anticipated key milestones for 2020
Mar 19, 2020: Cassava Sciences announces clinical update and business progress across Neuroscience pipeline
Oct 29, 2019: Cassava Sciences announces recent clinical highlights and third quarter 2019 financial results
Aug 12, 2019: Cassava Sciences announces second quarter 2019 financial results
Jun 18, 2019: Cassava Sciences to present at Maxim Group’s Conference on Alzheimer’s Disease
May 28, 2019: Cassava Sciences announces new website launch
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Cassava Sciences Inc, Key Facts
Cassava Sciences Inc, Key Employees
Cassava Sciences Inc, Key Employee Biographies
Cassava Sciences Inc, Major Products and Services
Cassava Sciences Inc, History
Cassava Sciences Inc, Key Competitors
Cassava Sciences Inc, Ratios based on current share price
Cassava Sciences Inc, Annual Ratios
Cassava Sciences Inc, Interim Ratios
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Cassava Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Cassava Sciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cassava Sciences Inc (SAVA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • bioMerieux SA (BIM):医療機器:M&Aディール及び事業提携情報
    Summary bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures and markets in vitro diagnostic solutions for private and hospital laboratories. The company offers diagnostic solutions such as systems, reagents and software. Its products are used to diagnose infectiou …
  • Vijaya Bank:企業の戦略・SWOT・財務情報
    Vijaya Bank - Strategy, SWOT and Corporate Finance Report Summary Vijaya Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Teikoku Seiyaku Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Teikoku Seiyaku Co Ltd (Teikoku Seiyaku) is a medical device company that develops, manufactures and distributes medicated and medically related supplies. The company offers Chinese medicine, other medicinal products, quasi-drugs, cosmetics, hot sensation plaster, transdermal indomethacin me …
  • Nordstrom Inc (JWN):企業の財務・戦略的SWOT分析
    Nordstrom Inc (JWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Norwegian Air Shuttle ASA:企業の戦略・SWOT・財務情報
    Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report Summary Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Staples Inc:企業の戦略的SWOT分析
    Staples Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • First Mutual Holdings Limited:企業の戦略・SWOT・財務情報
    First Mutual Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary First Mutual Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ICF International Inc (ICFI):企業の財務・戦略的SWOT分析
    ICF International Inc (ICFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Genisphere LLC-医療機器分野:企業M&A・提携分析
    Summary Genisphere LLC (Genisphere) is a nanotechnology company which provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapuetics. It develops pipeline produc …
  • Samart Corporation Public Co Ltd (SAMART):企業の財務・戦略的SWOT分析
    Samart Corporation Public Co Ltd (SAMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • RED HAT, INC.:企業の戦略・SWOT・財務情報
    RED HAT, INC. - Strategy, SWOT and Corporate Finance Report Summary RED HAT, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • E.ON SE:企業の発電所・SWOT分析2018
    E.ON SE - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Grupo Aval Acciones y Valores S.A.:戦略・SWOT・企業財務分析
    Grupo Aval Acciones y Valores S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones y Valores S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • PostNL NV (PNL):企業の財務・戦略的SWOT分析
    PostNL NV (PNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Flint Hills Resources LLC:企業の戦略的SWOT分析
    Flint Hills Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Realtek Semiconductor Corp. (2379):企業の財務・戦略的SWOT分析
    Realtek Semiconductor Corp. (2379) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Chugai Pharmaceutical Co Ltd (4519):製薬・医療:M&Aディール及び事業提携情報
    Summary Chugai Pharmaceutical Co Ltd (Chugai) is a subsidiary of Hoffmann-La Roche Ltd, which focuses on the research, development, manufacture, commercialization, import and export of the biopharmaceuticals and therapeutic antibodies. The company offers products for the treatment of cancer; bone an …
  • U.S. Concrete Inc (USCR):企業の財務・戦略的SWOT分析
    Summary U.S. Concrete Inc (US Concrete) is a construction company that manufactures and markets ready-mixed concrete and aggregates. The company’s aggregate products include crushed stone, sand and gravel used in commercial, industrial and public works. It also provides specialty products such as ra …
  • BC Technical Inc-医療機器分野:企業M&A・提携分析
    Summary BC Technical Inc (BC Technical), a subsidiary of MSouth Equity Partners is a medical device company that provides molecular imaging solutions. The company offers spare parts for new and refurbished nuclear medicine equipments for gamma cameras and BC backup server. It provides PET, PET/CT, N …
  • Candover Investments plc (CDI):企業の財務・戦略的SWOT分析
    Candover Investments plc (CDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆